CADTH Medical Device and Drug Portfolio Information Sessions

CADTH Medical Device Portfolio Information Session

10:00 a.m. to 12:00 p.m. EST

Health technology assessment (HTA) plays a key role in decisions about the use of medical devices in Canada. This session will cover the role of HTA in the management of medical devices in Canada, the programs in CADTH’s medical devices and clinical interventions portfolio, the assessment processes CADTH follows, and the opportunities for input and engagement by industry, patients, and other stakeholders. Updates on other relevant CADTH initiatives will also be provided. The session will include an open forum, where attendees can pose questions to CADTH President and CEO Dr. Brian O’Rourke, and other senior staff at CADTH.

The session will be presented in English and can be attended in person or via live broadcast. There is no charge to attend, but advance registration is required.

CADTH Drug Portfolio Information Sessions

1:30 p.m. to 4:00 p.m. EST

This annual session is an opportunity for all interested stakeholders to get the latest information about priority initiatives and process changes from CADTH’s pharmaceutical reviews portfolio. Updates on other relevant CADTH initiatives will also be provided. The session also includes an open forum, where attendees can direct questions to CADTH President and CEO Dr. Brian O’Rourke, and other senior staff at CADTH.

The session will be presented in English and can be attended in person or via live broadcast. There is no charge to attend, but advance registration is required.